Latest News
Merger of Two European CROs to Shake…
news
How OCT Clinical Completed Patient Recruitment…
cases
As the healthcare and life sciences industries have moved toward outsourcing models in clinical research, pharmaceutical and biotechnology companies face the challenge of finding the right Contract Research Organization (CRO) to assist in the clinical development of their treatments and medical devices.
Although they generally offer a similar range of services, not all CROs are created equal. Clinical research needs vary tremendously based on the company and the project itself. Below, we’ve listed some of the most important factors to consider in your CRO selection process.
With the right CRO, you can achieve much greater efficiency in your clinical trials. To learn why OCT Clinical Trials could be the right partner for your organization, talk to an expert today.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.